drugset / Trial / NCT07296341
HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a randomized, open-label, multicenter Phase II clinical trial designed to evaluate the Safety, Tolerability and Preliminary Efficacy of HRS-4642 Combination with Other Antitumor Therapies in Patients with Solid Tumors
Timeline
- Start
- 2026-01-08
- Primary completion
- 2027-10
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adebrelimab | Monoclonal antibody | — | — |
| Comparator | HRS-4642 | Unknown | — | — |
| Comparator | Gemcitabine | Small molecule | — | — |
| Comparator | Nab-paclitaxel | Small molecule | — | — |
Indications
No indication recorded.